Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School

Last Updated: December 14, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Pyridoxal

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the drug development status for Pyridoxal?

Pyridoxal is an investigational drug.

There have been 9 clinical trials for Pyridoxal. The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 2001.

The most common disease conditions in clinical trials are Reperfusion Injury, Movement Disorders, and Myocardial Ischemia. The leading clinical trial sponsors are Medicure, University of Alabama at Birmingham, and Beersheva Mental Health Center.

Recent Clinical Trials for Pyridoxal
Effect of Isoniazid on Protoporphyrin Levels in Erythropoietic ProtoporphyriaIcahn School of Medicine at Mount SinaiN/A
Effect of Isoniazid on Protoporphyrin Levels in Erythropoietic ProtoporphyriaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)N/A
Effect of Isoniazid on Protoporphyrin Levels in Erythropoietic ProtoporphyriaUniversity of Alabama at BirminghamN/A

See all Pyridoxal clinical trials

Clinical Trial Summary for Pyridoxal

Top disease conditions for Pyridoxal
Top clinical trial sponsors for Pyridoxal

See all Pyridoxal clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.